Indo Us Bio-Tech Peer Comparison
NSE: INDOUS | BSE: 541304
₹71.95
As on 16-Oct-2026IST
Market cap
₹147 Cr
Revenue (TTM)
₹113 Cr
P/E Ratio
12.8
P/B Ratio
1.5
Div. Yield
0 %
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
147 | 3,763 | 2,432 | 1,961 | 1,355 |
Revenue (₹ Cr) |
113 | 1,279 | 2,287 | 1,869 | 1,478 |
Net Profit (₹ Cr) |
11.46 | 248.50 | 103.30 | 78.36 | 125.12 |
Net Margin (%) |
10.15 | 19.09 | 4.51 | 4.13 | 8.40 |
RoE (%) |
12.79 | 14.05 | 15.85 | 14.22 | 15.66 |
Price to Earnings |
12.79 | 15.08 | 23.54 | 25.62 | 10.83 |
Price-To-Book |
1.53 | 1.85 | 1.76 | 3.16 | 1.71 |
Income Statement (₹ Cr)
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Operating Revenue
|
110.44 | 1,394.76 | 2,287.14 | 1,769.20 | 1,439.58 |
|
Total Income
|
110.49 | 1,426.49 | 2,291.67 | 1,805.85 | 1,450.30 |
|
Total Expenditure
|
93.42 | 1,060.37 | 2,061.92 | 1,678.90 | 1,282.85 |
|
EBITDA
|
17.02 | 334.39 | 225.22 | 90.30 | 156.73 |
|
Depreciation
|
0.90 | 60.01 | 6.45 | 3.47 | 4.64 |
|
EBIT
|
16.12 | 274.38 | 218.77 | 86.83 | 152.09 |
|
Interest
|
2.25 | 0.33 | 86.04 | 22.74 | 9.02 |
|
Other Income
|
0.05 | 31.73 | 4.53 | 36.66 | 10.72 |
|
Exceptional Items
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
13.92 | 305.79 | 137.26 | 100.75 | 153.79 |
|
Provision for Tax
|
0.80 | 9.95 | 33.96 | 24.70 | 39.01 |
|
Profit after Tax
|
13.12 | 295.83 | 103.30 | 76.04 | 114.78 |
Liabilities (₹ Cr)
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
92.53 | 1,756.78 | 924.13 | 601.61 | 838.20 |
|
Minority Interest
|
-- | -2.38 | -- | 3.95 | -- |
|
Non-Current Liabilities
|
0.56 | 87.06 | 4.35 | 4.58 | 75.80 |
|
Current Liabilities
|
39.52 | 970.17 | 1,192.91 | 549.98 | 125.70 |
|
Total Liabilities
|
133.10 | 2,811.64 | 2,121.39 | 1,160.13 | 1,039.70 |
Assets (₹ Cr)
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
11.93 | 750.71 | 93.26 | 57.26 | 167.74 |
|
Current Assets
|
120.69 | 2,060.93 | 2,028.13 | 1,102.87 | 871.96 |
|
Total Assets
|
133.10 | 2,811.64 | 2,121.39 | 1,160.13 | 1,039.70 |
|
Total Debt*
|
37.04 | 0.00 | 758.09 | 365.94 | 82.73 |
|
Net Current Assets
|
81.17 | 1,090.75 | 835.22 | 552.89 | 746.27 |
|
Contingent Liabilities
|
2.91 | 228.63 | 42.36 | 2.48 | -- |
Cashflow (₹ Cr)
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-12.58 | -6.47 | -166.37 | -53.59 | 51.17 |
|
Cash Flow from Investing Activities
|
-1.50 | 91.54 | 0.50 | -52.98 | -1.61 |
|
Cash from Financing Activities
|
19.96 | -63.96 | 402.51 | 82.27 | -49.45 |
|
Net Cash Inflow / Outflow
|
5.88 | 21.11 | 236.64 | -24.31 | 0.10 |
Ratios
Profitability Ratios
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
ROCE (%)
|
14.51 | 18.80 | 15.70 | 14.09 | 20.13 |
|
ROE (%)
|
15.34 | 18.17 | 15.85 | 15.37 | 16.26 |
|
ROA (%)
|
11.42 | 10.74 | 5.63 | 7.34 | 11.44 |
|
EBIT Margin (%)
|
15.46 | 26.25 | 10.05 | 7.18 | 11.63 |
|
Net Margin (%)
|
11.88 | 20.74 | 4.51 | 4.21 | 7.91 |
|
Cash Profit Margin (%)
|
12.70 | 25.51 | 4.80 | 4.49 | 8.30 |
Growth Ratios
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
6.36 | 15.75 | 14.26 | 31.23 | -3.72 |
|
EBIT Growth (%)
|
-10.70 | 8.56 | 38.37 | 20.22 | 11.82 |
|
Net Profit Growth (%)
|
-19.33 | 4.80 | 69.84 | 24.18 | 11.57 |
|
EPS Growth (%)
|
-19.33 | 5.16 | 34.56 | 4.72 | 11.57 |
|
Book Value Growth (%)
|
17.85 | 17.18 | 143.72 | 53.89 | 16.06 |
Valuation Ratios
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Price / Earnings
|
14.96 | 13.58 | 0.00 | 43.29 | 8.93 |
|
Price / Book Value
|
2.12 | 2.29 | 0.00 | 5.27 | 1.35 |
|
Dividend Yield (%)
|
0.00 | 0.64 | -- | 0.00 | 1.46 |
|
EV/EBITDA
|
13.31 | 10.86 | 2.64 | 27.21 | 5.84 |
|
Market Cap (₹ Cr)
|
196.31 | 4,018.73 | 0.00 | 3,162.08 | 1,024.55 |
Solvency Ratios
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.40 | 0.00 | 0.82 | 0.61 | 0.11 |
|
Short term debt to equity ratio
|
0.37 | -- | 0.82 | 0.61 | 0.01 |
|
Current Ratio
|
3.05 | 2.12 | 1.70 | 2.01 | 6.94 |
|
Quick Ratio
|
0.52 | 0.88 | 0.83 | 1.21 | 3.54 |
|
Interest Coverage
|
7.19 | 935.55 | 2.60 | 5.43 | 18.04 |
Operating Efficiency Ratios
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
12.46 | 8.06 | 21.65 | 32.61 | 16.22 |
|
Asset Turnover
|
0.96 | 0.51 | 1.25 | 1.71 | 1.43 |
|
Receivable days
|
47.52 | 26.80 | 75.43 | 109.04 | 58.57 |
|
Inventory Days
|
281.98 | 292.88 | 156.91 | 77.26 | 109.15 |
|
Payable days
|
148.07 | 307.75 | 24.65 | 9.11 | 3.40 |
|
Cash Conversion Cycle
|
181.43 | 11.93 | 207.69 | 177.19 | 164.32 |